The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| E-Paper
Search
+

    Buy Cipla, target Rs 645: Dr CK Narayan

    Synopsis

    Buy Cipla Ltd. at a price target of Rs 645.0 and a stoploss at Rs 625 from entry point.

    ThinkStock Photos

    Related Companies

    NSE
    BSE

    PEER COMPANIES

    Dr CK Narayan of Chart Advise has a buy call on Cipla Ltd. with a target price of Rs 645.0 . The current market price of Cipla Ltd. is Rs 633.4 Time period given by the analyst is Intra Day when Cipla Ltd. price can reach the defined target. Dr CK Narayan recommended to keep stoploss at Rs 625. Cipla Ltd., incorporated in 1935, is a largecap company with a market cap of Rs 51002.43 crore.

    Cipla Ltd. key Products/Revenue Segments include Tablets & Capsules which contributed Rs 6163.98 Crore to Sales Value (56.16 % of Total Sales), Injections/Sterile Solution which contributed Rs 1506.33 Crore to Sales Value (13.72 % of Total Sales), Aerosols which contributed Rs 1276.00 Crore to Sales Value (11.62 % of Total Sales), Bulk Drugs which contributed Rs 862.17 Crore to Sales Value (7.85 % of Total Sales), Liquids which contributed Rs 466.89 Crore to Sales Value (4.25 % of Total Sales), Creams which contributed Rs 307.84 Crore to Sales Value (2.80 % of Total Sales), Export Incentives which contributed Rs 162.31 Crore to Sales Value (1.47 % of Total Sales), Other Operating Revenue which contributed Rs 112.22 Crore to Sales Value (1.02 % of Total Sales), Others which contributed Rs 53.87 Crore to Sales Value (0.49 % of Total Sales), Other Services which contributed Rs 36.44 Crore to Sales Value (0.33 % of Total Sales) and Scrap which contributed Rs 26.53 Crore to Sales Value (0.24 % of Total Sales)for the year ending 31-Mar-2017.

    For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 3845.84 Crore, up 10.01 % from last quarter Sales of Rs 3495.81 Crore and up 12.05 % from last year same quarter Sales of Rs 3432.32 Crore Company has reported net profit after tax of Rs 446.68 Crore in latest quarter. The company’s top management includes Dr.Peter Mugyenyi, Dr.Y K Hamied, Mr.Adil Zainulbhai, Mr.Ashok Sinha, Mr.M K Hamied, Mr.Peter Lankau, Mr.S Radhakrishnan, Mr.Umang Vohra, Ms.Ireena Vittal, Ms.Naina Lal Kidwai, Ms.Punita Lal, Ms.Samina Vaziralli. Company has Walker Chandiok & Co. LLP as its auditoRs As on 30-06-2018, the company has a total of 805,191,188 shares outstanding.
    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

    Also Read

    The Economic Times